We are pleased to announce publication of the collaborative assessment OTCA09 “High-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer”.
This is the assessment of the relative effectiveness of high-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer. The purpose of the assessment is to evaluate the relative effectiveness and safety of high-intensity focused ultrasound as primary therapy or as salvage therapy for the treatment of clinically localised or locally relapsed prostate cancer in comparison to deferred treatment strategies (active surveillance, watchful waiting) and/or standard radical treatment strategies (radical prostatectomy, radiation therapy).
OTCA09_HIFU for prostate cancer
OTCA09_Comments of external reviewer
Project Plan external reviewer comments and authors’ answers
